| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 14 securities · passive | ||||||
|
Equillium, Inc.
13G/A
EQ · 29446K106
|
7.0% |
11/4/2026
Event 9/30/2026
|
||||
| Aberdeen Group plc | 7.0% | |||||
| abrdn Inc. | 7.0% | |||||
|
Immunic, Inc.
13G/A
IMUX · 4525EP200
|
8.0% |
11/2/2026
Event 9/30/2026
|
||||
| Aberdeen Group plc | 8.0% | |||||
| abrdn Inc. | 8.0% | |||||
|
Codexis, Inc.
13G/A
CDXS · 192005106
|
9.9% |
10/30/2026
Event 9/30/2026
|
||||
| Aberdeen Group plc | 9.9% | |||||
| abrdn Inc. | 9.9% | |||||
|
Freenome, Inc.
13G/A
PCSC · G70077105
|
0.6% |
10/29/2026
Event 9/30/2026
|
||||
| Aberdeen Group plc | 0.6% | |||||
| abrdn Inc. | 0.6% | |||||
|
Corbus Pharmaceuticals Holdings, Inc.
13G/A
CRBP · 21833P301
|
0% |
10/29/2026
Event 9/16/2026
|
||||
| Aberdeen Group plc | 0% | |||||
| abrdn Inc. | 0% | |||||
|
Tectonic Therapeutic, Inc.
13G/A
TECX · 878972108
|
2.5% |
10/29/2026
Event 9/30/2026
|
||||
| Aberdeen Group plc | 2.5% | |||||
| abrdn Inc | 2.5% | |||||
|
ProQR Therapeutics NV
13G
PRQR · N71542109
|
6.3% |
7/29/2026
Event 6/30/2026
|
||||
| Aberdeen Group plc | 6.3% | |||||
| abrdn Inc. | 6.3% | |||||
|
Eloxx Pharmaceuticals Inc
13G
ELOX · 29014R103
|
9.9% |
7/27/2026
Event 6/30/2026
|
||||
| Aberdeen Group plc | 9.9% | |||||
| abrdn Inc. | 9.9% | |||||
|
uniQure N.V.
13G/A
QURE · N90064101
|
4.5% |
7/20/2026
Event 6/30/2026
|
||||
| Aberdeen Group plc | 4.5% | |||||
| abrdn Inc. | 4.5% | |||||
|
Sera Prognostics, Inc.
13G/A
SERA · 81749D107
|
7.2% |
7/15/2026
Event 6/30/2026
|
||||
| Aberdeen Group plc | 7.2% | |||||
| abrdn Inc. | 7.2% | |||||
|
Quoin Pharmaceuticals, Ltd.
13G/A
QNRX · 74907L409
|
4.2% |
4/29/2026
Event 4/1/2026
|
||||
| Aberdeen Group plc | 4.2% | |||||
| abrdn Inc. | 4.2% | |||||
|
InspireMD, Inc.
13G/A
NSPR · 45779A846
|
7.5% |
2/2/2026
Event 12/31/2025
|
||||
| Aberdeen Group plc | 7.5% | |||||
| abrdn Inc. | 7.5% | |||||
|
Immunic, Inc.
13G/A
IMUX · 4525EP101
|
6.9% |
2/2/2026
Event 12/31/2025
|
||||
| Aberdeen Group plc | 6.9% | |||||
| abrdn Inc. | 6.9% | |||||
|
Precision BioSciences, Inc.
13G
DTIL · 74019P207
|
8.9% |
1/27/2026
Event 12/31/2025
|
||||
| Aberdeen Group plc | 8.9% | |||||
| abrdn Inc. | 8.9% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.